Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Prepaid Assets (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Prepaid Assets for 2 consecutive years, with $5.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Prepaid Assets rose 107.33% to $5.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.3 million, a 107.33% increase, with the full-year FY2024 number at $4.0 million, changed N/A from a year prior.
  • Prepaid Assets was $5.3 million for Q3 2025 at Pyxis Oncology, down from $6.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $6.5 million in Q2 2025 to a low of $2.6 million in Q3 2024.